NCT01583920View on ClinicalTrials.gov

Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Prostate Cancer
Interventions
RADIATION

focal salvage HDR prostate brachytherapy

Treatment will be delivered using 192-Ir HDR afterloading. Dose prescription is 2 fractions of 13.5 Gy each, delivered 1 week apart.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto

All Listed Sponsors
collaborator

Canadian Association of Radiation Oncology

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT01583920 - Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer | Biotech Hunter | Biotech Hunter